UPLOAD Filing
Apimeds Pharmaceuticals US, Inc.
Date: May 5, 2025 · CIK: 0001894525 · Accession: 0000000000-25-004732
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-42545
Letter
Re: Apimeds Pharmaceuticals US, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-42545 Dear Mark Corrao:
May 5, 2025
Mark Corrao Chief Financial Officer Apimeds Pharmaceuticals US, Inc. 2 East Broad Street 2nd Floor Hopewell, NJ 08425
We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> May 5, 2025 Mark Corrao Chief Financial Officer Apimeds Pharmaceuticals US, Inc. 2 East Broad Street 2nd Floor Hopewell, NJ 08425 Re: Apimeds Pharmaceuticals US, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 File No. 001-42545 Dear Mark Corrao: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>